FEATURED ARTICLES

• Fast And Scalable Fc Quantitation In Supernatants

  In biopharmaceutical development, the Fc PAIA Titer assay offers a fast, cost-effective, and automatable solution for high-throughput Fc quantification to enhance efficiency, support research, and accelerate production advancements.

• Evaluating Compound Toxicity Effects On Healthy Intestinal Organoids

  3D organoids enhance drug toxicity prediction and are crucial for anti-cancer drug development. Examine a method using 3D mouse intestinal organoids that aims to provide vital data on intestinal toxicity.

• Engineering The Future: Synthetic Biology For A Sustainable World

  Synthetic biology merges biology, engineering, and technology to create new biological systems. Explore its transformative impact on industries, sustainability, and the pioneering research driving this exciting field.

• From Lab To Table: Sustainable Solutions For A Growing World

  As climate change and resource scarcity intensify, cultivated meat emerges as a sustainable, ethical alternative to traditional farming. Discover its potential, innovations, and the industry leaders driving this revolution.

• CRISPR CAS 9 Gene Editing: The Art Of DNA Design

  Explore CRISPR-Cas9's transformative potential in healthcare as well as its principles, innovations, and global applications to gain valuable insight into transforming your approach to gene editing.

• Techniques, Automation, And Applications In Molecular Biology

  Imagine a world where biotechnology streamlines your research. Discover automated colony pickers, UV sanitization, and high-resolution imaging to ensure efficiency and sterility in your cell lines.

• Optimize Your High-Value Cell Lines

  Discover high-throughput solutions designed to accelerate the selection of high-producing mammalian cell lines and how recombinant cell lines are projected to exceed $10 billion by 2030.

• Cell Culture Automation Of The 3D Cancer Spheroid Assay

  Discover how automated 3D cell culture methods enhance efficiency and consistency in high-throughput drug screening to accelerate the discovery of new anti-cancer therapies.

• mTOR Pathway

  Explore the mTOR signaling pathway and reveal how mTORC1 regulates cell growth, metabolism, and survival to ensure cellular function and adaptation to environmental cues.

• VEGF Signaling Pathway

  In Alzheimer's disease, reduced VEGF levels are linked to neurodegeneration, which can offer therapeutic potential. Discover how experimental treatments show promise in reducing memory impairment and beta-amyloid deposition.

• Neuroinflammation In Alzheimer's Disease Pathway

  Recent research highlights neuroinflammation's role in AD progression, which suggests immune modulation as a potential therapeutic strategy. Learn more about neuroinflammatory processes in AD pathology.

• Alzheimer's Disease Pathway

  Alzheimer’s disease (AD) affects 50 million people globally, causing cognitive decline. Explore the signaling pathways of amyloid beta and tau proteins, linking them to neuronal death and AD symptoms.

• Studying The Spatial Architecture Of Glioblastoma

  Explore how intra-tumor heterogeneity (ITH) impacts cancer progression and therapy resistance with advanced imaging platforms and custom antibody panels to reveal the spatial architecture of glioblastoma (GBM).

• Multiplex Imaging

  Explore recombinant antibody reagents that support the imaging of key targets within the TME and offer flexible solutions across various platforms to improve patient outcomes.

• Enhanced Validation Data Anti-EGFRvIII Recombinant Antibody

  Select the right antibody clone by exploring enhanced validation data for top recombinant antibody clones that offer comprehensive specificity and sensitivity insights tailored to your project's unique requirements.

• Assessment Of Compound Toxicity Effects With High-Content Imaging

  3D cellular models and bioprinting enhance drug safety predictions and offer precise spatial control. Explore an automated method for generating liver models to improve reproducibility and reliability in toxicity testing.

• Automation Of iPSC Culture, Passaging, And Expansion

  Find out how iPSC-derived models enable researchers to generate diverse cell types and tissues as well as how automation reduces the labor-intensive culturing process with AI-powered decision-making.

• Automation Of 3D Intestinal Organoids Culture

  Gain insight into how 3D organoids promise better disease modeling and drug screening and how challenges like assay complexity, reproducibility, and scalability hinder their widespread adoption in drug discovery.

• Automating High-Throughput Screens Using Patient-Derived Organoids

  Many oncology drugs fail in later development stages due to inadequate predictive models. Explore how 3D cell models, like patient-derived organoids, offer a promising solution in the drug development process.

• Automated Testing For Compound Toxicity Effects

  Explore how anti-cancer drugs' toxic effects on intestinal cells limit dosages as well as how 3D organoids and assay automation can enhance drug development by improving testing processes.